|1||PROCROP Professional cross-priming for ovary and prostate cancer||2015||7˙572˙500.00||5˙750˙000.00|
|2||TARGEPILIVER Characterization of Key Epigenetic Targets in Hepatic Fibrosis and Hepatocellular Carcinoma Development. Generation of New Antifibrotic and Antitumoral Drugs.||2015||170˙121.00||170˙121.00|
|3||CINK Advancing cancer immunotherapy using natural killer cells for hematological and metastatic cancers||2018||158˙121.00||158˙121.00|
|4||NONCHROREP Investigating the role of the long noncoding transcriptome in chromatin replication||2018||2˙000˙000.00||2˙000˙000.00|
|5||LINKER Elucidating transcriptional rewiring on hematological malignancies via computational methods||2020||172˙932.00||172˙932.00|
|6||SYLENCE Synapses between Leukaemia and its Neighbouring Cells||2020||160˙932.00||160˙932.00|
The Institution FUNDACION PARA LA INVESTIGACION MEDICA APLICADA FIMA has been involved also in the following Horizon 2020 projects.